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CopperS100B is a homodimeric zinc-, copper-, and calcium-binding protein of the family of EF-hand S100 proteins.
Zn2+ binding to S100B increases its afﬁnity towards Ca2+ as well as towards target peptides and proteins.
Cu2+ and Zn2+ bind presumably to the same site in S100B.We determined the structures of human Zn2+- and
Ca2+-loaded S100B at pH 6.5, pH 9, and pH 10 by X-ray crystallography at 1.5, 1.4, and 1.65 Å resolution,
respectively. Two Zn2+ ions are coordinated tetrahedrally at the dimer interface by His and Glu residues from
both subunits. The crystal structures revealed that ligand swapping occurs for one of the four ligands in the
Zn2+-binding sites. Whereas at pH 9, the Zn2+ ions are coordinated by His15, His25, His 85′, and His 90′, at pH
6.5 and pH 10, His90′ is replaced by Glu89′. The results document that the Zn2+-binding sites are ﬂexible to
accommodate other metal ions such as Cu2+. Moreover, we characterized the structural changes upon Zn2+
binding, which might lead to increased afﬁnity towards Ca2+ as well as towards target proteins. We observed
that in Zn2+–Ca2+-loaded S100B the C-termini of helix IV adopt a distinct conformation. Zn2+ binding
induces a repositioning of residues Phe87 and Phe88, which are involved in target protein binding. This article
is part of a Special Issue entitled: 11th European Symposium on Calcium.ichroism
opean Symposium on Calcium.
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lsevier B.V.© 2010 Published by Elsevier B.V.S100B is a small (10.7 kDa) Zn2+- and Ca2+-binding EF-hand
protein that is highly expressed in astrocytes [1] and constitutes with
0.5% one of the most abundant soluble proteins in brain. It is a
member of the S100 protein family, which represents with 21
members the largest subgroup in the EF-hand protein superfamily
[1,2] as well as larger multimers. We recently identiﬁed and
structurally characterized tetra-, hexa-, and octameric species of
S100B [3] as well as larger multimers. Further multimers are reported
for S100A12 and S100A8/A9 heterodimer. S100B is involved in
cellular processes such as cell growth, cell cycle control [4], and
differentiation [5]. Intracellularly, S100B binds in Ca2+-dependent
manner to cytoskeletal proteins such as annexin II, tubulin ﬁlaments,
or CapZ [1,2]. Moreover, it is involved in the regulation of metabolic
enzymes like aldolase [6] and glycogen phosphorylase [7]. S100B
transfers the Ca2+ signal into phosphorylation status by interaction
with kinases such as NDR-kinase [8] or interaction with proteins
regulated by phosphorylation like transcription factor p53 [9] andmicrotubule-associated tau protein [10]. In addition to its intracellular
function as Ca2+ sensor S100B is secreted to the extracellular space
where it exhibits cytokine-like functions. It was shown that S100B is
secreted by vesicular transport from gliablastoma cells upon changes
in intracellular Ca2+ or Zn2+ levels [11]. Once secreted, S100B exerts
dose dependent neurotrophic [12,13] or neurotoxic action [13].
Altered expression levels of S100B are associated with neurodegen-
erative disorders like Alzheimer’s disease [14,15] and cancer [1,16].
Besides Ca2+, several S100 proteins bind Zn2+ with high afﬁnity.
The different Zn2+-binding S100 proteins can be sorted into two
groups. Members of the ﬁrst group bind Zn2+ via Cys residues and
comprise S100A2 [17], S100A3 [18,19], S100A4 (Koch et al.,
unpublished results), and S100A6 [20], whereas members of the
second group like S100A7, S100A8/A9, S100A12, and S100B coordi-
nate Zn2+ only with residues Asp, His, or Glu. In contrast to Cys, these
residues cannot undergo redox reactions and are also suited to
coordinate the redox labile Cu2+. In fact, several S100 proteins are
reported to bind Cu2+ with high afﬁnity [20–23]. The structures of
S100A12 in complex with Cu2+ [20] or Zn2+ [24] illustrate that the
metal ions bind to identical sites suggesting that the other Zn2+-
binding S100 proteins display similar ﬂexibility with regard to nature
of the bound metal ion. This ﬂexibility to accommodate different
metal ions must be reﬂected in speciﬁc structural properties of the
site. So far structural information is available from the crystal
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structure rat S100B in the Ca2+–Zn2+-loaded state [25], the crystal
structure of Ca2+–Zn2+-loaded state [20] and from the X-ray
structures of bovine Ca2+–Zn2+-loaded S100B [26], Ca2+–Cu2+-
loaded S100A12, the Cu2+ binding to the Zn2+ sites [20]. S100B
binds Zn2+ with higher afﬁnity than Ca2+. Zn2+-binding afﬁnities of
20 nM and 100 nM were determined by ﬂuorescence titrations for
bovine S100B [27] and by isothermal calorimetry for rat S100B [28],
respectively. It was shown that Zn2+ binding to S100B increases its
afﬁnity towards Ca2+ [27] as well as towards peptides derived
from target proteins [29–32]. The structures of Ca2+–Zn2+-loaded
S100B from rat determined by multidimensional NMR spectroscopy
and Ca2+–Zn2+-loaded S100B from bovine by X-ray crystallography
revealed that two Zn2+ ions bind per homodimer [26,32] at a site
similar to the Cu2+-binding site in S100A12 [20]. At neutral pH, the
Zn2+ ions are coordinated by three His and one Glu residues
originating from both subunits in the homodimeric protein. However,
spectroscopic data on Cu2+-loaded S100B revealed that Cu2+ is
coordinated by four equivalent N atoms originating most likely from
four histidine residues [21] (Koch, M., Ostendorp, T., Antholine, W.A.,
Kroneck, P.M.H., Fritz, G. publication in preparation), suggesting some
ﬂexibility of the site in S100B. In order to get detailed structural
information on this versatile metal ion binding site in S100B and the
structural changes upon accompanied with metal ion binding, we
determined the structure of human Ca2+–Zn2+-loaded S100B at three
different pH values by X-ray crystallography. We report here on three
high-resolution crystal structures of Zn2+–Ca2+-loaded human S100B
exhibiting a ﬂexible Zn2+-binding site and structural changes, which
might lead to an increased afﬁnity towards target proteins.
1. Materials and methods
1.1. Crystallization
Recombinant dimeric human S100B was expressed and puriﬁed as
described previously [33]. S100B in 10 mM Tris–HCl pH 7.6 was
concentrated by ultraﬁltration to 10 mg ml−1 (0.46 mM dimer) and
10 mM CaCl2, 0.92 mM ZnCl2 were added. Crystallization trials were
performed by the sitting-drop vapor diffusion method mixing 2 μl
drops of protein solution with 2 μl out of 500 μl reservoir. Diffracting
crystals were obtained with 0.1 M MES pH 6.5 21% PEG5000MME, or
0.05 M TAPS pH 9.0, 30% PEG4000, or 0.05 M CAPS pH 10.0, 23%
PEG5000MME as precipitant. The crystals grew within 2–4 weeks at
16 °C (at pH 6.5) or 18 °C (at pH 9.0 and pH 10.0). Crystals grown at
pH 6.5 and pH 10 belonged to the space group P21 or when grown atTable 1
Data collection and reﬁnement statistics.
Crystallization pH pH 6.5
Space group P21
Unit cell parameters (Å) a=34.89, b=58.15
c=47.66
α=γ=90°, β=111.12°
Resolution 13–1.50 (1.6–1.5)
Completeness (%) 97.0 (93.4)
No. of unique reﬂections 27707 (4677)
Redundancy 3.8 (3.4)
Rmerge (%) 7.7 (51.7)
I/σ(I) 8.5 (2.3)
SU per asymmetric unit 2
Rcryst (%) 20.5 (26.3)
Rfree
a (%) 25.9 (34.0)
RMS deviation from ideal geometry:
Bond distances (Å) 0.015
Bond angles (degree) 1.52
The numbers in parentheses are the statistics for the highest resolution shell.
aRfree was calculated against 5% of the total reﬂections omitted from the reﬁnement.pH 9.0 to the space group C2221. The crystals were immersed for 5 s in
cryo-protectant solution prior data collection and ﬂash-frozen in the
cryo-nitrogen stream. The cryo-protectant solution contained 0.1 M
MES pH 6.5, 33% PEG5000MME, 0.02 M TAPS pH 9.0 32% PEG4000,
and 0.02 M CAPS pH 10.0 30% PEG5000 MME, respectively.1.2. Spectroscopy
Far UV CD spectra of S100B were recorded with a spectro-
polarimeter J-715 (Jasco) in 0.10- and 0.01-cm quartz cells at 20 °C.
The protein concentration was 5 μM in 20 mM Tris-Cl, pH 7.5. Six
spectra of protein were recorded between 260 and 180 nm, averaged
and corrected for the buffer spectrum. Difference spectra were
calculated from dilution corrected spectra of metal-ion-loaded
S100B and apo-S100B. UV–Vis spectra of Co2+ substituted S100B
were recorded in 1-cm quartz cells under exclusion of dioxygenwith a
Cary3 (Varian) spectrophotometer at 20 °C. Protein concentration
was 285 μM in 20 mM Tris–Cl, pH 7.6. Divalent metal ions were
removed from all buffers by Chelex (Bio-Rad) treatment.1.3. X-ray data collection
Data sets were collected using synchrotron radiation at the Swiss
Light Source (SLS) beamline X06SA equipped with a MAR225 CCD
detector at 100 K. All data were scaled and processed using the
program package XDS [34,35]. Crystal parameters and data collection
statistics are listed in Table 1.1.4. Structure determination and crystallographic reﬁnement
The structure of human Ca2+–Zn2+-loaded S100B was solved by
molecular replacement by CNS [36] and MOLREP [37]. The subunits A
and B of the human Ca2+–S100B served as a search model [38]. The
model was reﬁned with REFMAC5 [39] implemented in the CCP4
package [40]. Assignment of TLS groups for reﬁnement was done by
TLSMD server [41]. Solvent positions were determined using ARP/
wARP [42]. Repeated cycles of manual rebuilding of the models were
done after each reﬁnement step with the programs O [43] and Coot
[44]. The quality and geometry of the structures were evaluated by
PROCHECK [45]. Illustrations and structural alignments were pre-
pared using the program Pymol [46]. The coordinates and structure
factors have been submitted to the Protein Data Bank with accession
codes 3DOY, 3CZT, and 3D10.pH 9.0 pH 10.0
C2221 P21
a=34.95, b=89.26 a=34.75, b=58.18
c=59.58 c=47.85
α=β=γ=90° α=γ=90°, β=111.08°
18–1.40 (1.55–1.4) 44–1.65 (1.75–1.65)
97.0 (89.2) 98.6 (95.8)
18236 (4340) 21394 (3392)
5.8 (2.9) 3.5 (3.0)
5.2 (21.3) 5.3 (29.0)
18.4 (5.1) 13.5 (3.5)
1 2
16.1 (19.3) 20.9 (25.6)
22.1 (28.0) 27.5 (33.6)
0.019 0.021
1.49 1.90
Table 2
Interhelical angles and distances of Zn2±–Ca2±–S100B structures and compared to
other S100 structures.
Interhelical angle
(degrees)
Interhelical
distances (Å)
I–II II–III III–IV I–II II–III III–IV
1Human Zn–Ca–S100B, pH 6.5 137 100 106 15.5 11.6 15.7
2Human Zn–Ca–S100B, pH 9 138 100 107 15.4 11.8 15.0
3Human Zn–Ca–S100B, pH 10 138 101 106 15.4 11.7 15.0
4Human Ca–S100B (pH 7.5) 135 101 104 15.1 11.8 15.7
5 Bovine Ca–S100B, (pH 7.5) 135 101 103 15.2 11.9 15.6
6Rat Zn–Ca–S100B (NMR pH 7.2) 130 129 140 14.6 11.0 8.5
7Bovine Zn–Ca–S100B (X-ray pH 7.2) 137 100 103 14.7 11.7 15.4
8Human Cu–Ca–S100A12 142 107 120 14.2 11.3 15.7
9Human Zn–Ca–S100A7 138 127 130 16.0 11.3 14.0
1(3DOY), 2(3CZT), 3(3D10) this study, 4(2 H61) , 5(1MHO) [64], 6(1XYD) [32], 7(3CR2) [26],
8(1ODB) [20], 9(2PSR) [25]. Helices were assigned using DSSP [65]; helix I was deﬁned as
residues 2–18; helix II, residues 29–39; helix III, residues 51–60; and helix IV, residues 70–
87.
Fig. 1. Overall structure of Zn2±–Ca2±-loaded S100B and structure Zn2±-binding sites. Overa
pH 10.0. The Zn2+ coordinating residues (His and Glu) are shown in stick type. The subuni
shown as magenta spheres. The overall fold and the location of the Zn2+-binding site are ver
tetrahedrally by His15(Nε); His25(Nε) from one subunit and by His85′(Nε) and Glu89′ f
coordinated by His15; His25, His85′, and His90′. Glu89′ that is coordinating Zn2+ at pH 6.5 a
pointingwith its side chain to the opposite direction of the Zn2+-binding site. (F) Zn2+-bindin
The electron density around the coordinating residues and the Zn2+ ions is shown in green
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2.1. Crystallization and reﬁnement
The protein crystallized only in the presence of equimolar amounts
of Zn2+ and excess amounts of Ca2+. Addition of excess of Zn2+ led to
precipitation of the protein. Crystals grown in space group P21
contained one dimer per asymmetric unit, whereas the crystal grown
at pH 9.0 belonged to space group C2221 and contained only one
subunit per asymmetric unit. In this case, the full dimer was obtained
by crystallographic symmetry operations. The crystals obtained at pH
6.5 and 10.0 diffracted to 1.6 and 1.5 Å resolution and were reﬁned
using 4 TLS groups for each subunit resulting in Rcryst=20.5
(Rfree=25.9) and Rcryst=20.9 (Rfree=27.5), respectively. Crystals
grown at pH 9.0 diffracted to 1.4 Å and the structure and individual
anisotropic B-factor reﬁned for all atoms. Including hydrogen atoms in
riding positions in the last cycles of reﬁnement resulted in a drop of
0.9% in Rcryst and 1.5% in Rfree to ﬁnal Rcryst of 16.1% and Rfree of 22.1%.ll structure of S100B dimer at different pH values. (A) at pH 6.5, (B) at pH 9.0, and (C) at
ts are colored in blue and cyan. Ca2+ ions are shown as yellow spheres, Zn2+ ions are
y similar in all three structures. (D) Zn2+-binding site at pH 6.5. The Zn2+ is coordinated
rom the second subunit. (B and E) The Zn2+-binding site at pH 9.0, the Zn2+ ion is
nd 10.0 is shown in stick type. Coordination by His90′ leads to a reorientation of Glu89′
g site of S100B at pH 10. The Zn2+ ion is coordinated by His15 His25, His85′, and Glu89′.
at 1.5σ.
Table 3
Table 2: zinc–ligand distances
Zn to ligand pH 6.5a pH 9.0 pH 10.0a
His15 NE2 (Å) 2.00±0.02 2.07 2.11±0.06
His25 NE2 (Å) 1.95±0.04 1.86 1.90±0.05
His85 NE2 (Å) 2.16±0.02 2.13 2.15±0.03
His90 NE2 (Å) – 1.88 –
Glu89 OE (Å) 1.98±0.05 – 2.46±0.18
a Mean distances and standard deviations of both Zn2+ sites in S100B homodimer.
1086 T. Ostendorp et al. / Biochimica et Biophysica Acta 1813 (2011) 1083–1091The somewhat higher R values for the structures at pH6.5 and pH
10.0 might be a result of the less ordered C-terminus compared to the
structure at pH 9.0. In the structure at pH 9.0, the Zn2+ is coordinated
in the fourth position by His90, whereas in the other two structures,
Glu89 is coordinating. The coordination by His90 leads to a higher
ordered C-terminus that could bemodeled better resulting in lower R-
factors. For details, see Table 1.
The packing of S100B molecules is very similar in both crystal
forms although crystals of at pH 6.5/pH 10 belong to a different space
group than crystals grown at pH 9.0. Closer inspection of the
symmetry axis shows that in the crystals grown at pH 9.0 the
intrinsic twofold symmetry axis of the S100B homodimers is a true
crystallographic axis. Therefore, the same axis exists in the lower
symmetry space group P21 as well as in the higher symmetry space
group C2221 without affecting packing.
2.2. Overall structure
Zn2+–Ca2+-loaded S100B is a homodimeric heart-shaped mole-
cule stabilized by hydrophobic interactions between the two subunits.Fig. 2. Comparison of Zn2±-binding sites in S100B with Zn2±/Cu2±-binding sites of S100A7
(magenta) (B), and pH 10.0 (cyan) (C) in superposition with Zn2+/Cu2+-binding sites of S100
Zn2+-binding sites in S100B determined in this study. The ions are shown as spheres, yellow
Cu2+ ion is in green.The overall fold of Zn2+–Ca2+–S100B is very similar to that of Ca2+-
loaded S100B or other dimeric Ca2+-loaded S100 proteins. Each
subunit comprises two helix–loop–helix EF-handmotifs connected by
a further loop. All three structures at pH values of pH 6.5, 9, and 10
revealed two Zn2+ ions and four Ca2+ ions bound per homodimer. The
relative height of the anomalous signals for Zn2+ and Ca2+ ions
showed that all metal-ion binding sites are fully occupied. The three
structures of Zn2+–Ca2+–S100B show a very similar fold as illustrated
by RMSDs for the Cα (residues 1–89) positions of approximately 0.2 Å
and by the interhelical angles and distances (helix pair I–II=138±1°,
15 Å; helix pair III–IV=106±1°, 15 Å, see also Table 2). Thus, the
overall fold of Zn2+–Ca2+–S100B does not change in a pH range from
6.5 to 10.0 (Fig. 1A–C). Nevertheless, variation in the type of Zn2+
coordination occurs in the different structures. In the following, we
will compare the structures obtained at the three different pH values.
In order to differentiate the structures, we will use the different pH
values as an assignment.
2.3. Structure of the Zn2+-binding sites exhibit ligand swapping
In all three structures, the two Zn2+ ions in S100B dimer are
coordinated in a distorted tetrahedron by residues from both subunits
(Fig. 1D–F). In the structures obtained at pH 6.5 and pH 10, histidines
His15, His25 from one subunit and His85′ and a Glu89′ from the
second subunit serve as ligands (Fig. 1D, F). The same ligands have
been identiﬁed in rat and bovine Zn2+–Ca2+–S100B determined at pH
7.2 [26,32]. In contrast to these structures in Zn2+–Ca2+–S100B at
pH 9, the Zn2+ ions are coordinated by the four histidines His15,
His25, His85′, and His90′ (Fig. 1E). This type of coordination is in
agreement with the observed coordination of Cu2+ in S100Band S100A12. Residues of Zn2+-binding site in S100B at pH 6.5 (yellow) (A), pH 9.0
A7 (orange, pdb code 2PSR) and S100A12 (green, pdb code 1ODB). (D) Superposition of
/magenta/cyan is for the S100B Zn2+ ions, S100A7 Zn2+ ion is in orange, and S100A12
1087T. Ostendorp et al. / Biochimica et Biophysica Acta 1813 (2011) 1083–1091determined by EPR spectroscopy [21]. The ligand swapping probably
enables S100B to accommodate further metal ions such as Cu2+,
which prefers nitrogen over oxygen coordination and contributes to
functional ﬂexibility of S100B. All histidine residues coordinate Zn2+
via the imidazole Nε atom. Zn2+–ligand distances were not ﬁxed
during reﬁnement in order to get an unbiased view of the Zn2+-
binding site. The Zn2+ to nitrogen and oxygen distances vary in a
certain range but are in agreement with previously observed Zn2+–
ligand distances in proteins [47] (for details, see Table 3).
A similar type of coordination has been shown for Cu2+ in the
Cu2+–Ca2+-loaded S100A12 (His15, His85′ and His89′, and Asp25,
Fig. 2A–C) [20] and for the Zn2+-loaded S100A7 (His15, His85′ and
His89′, and Asp25, Fig. 2A–C). In the case of Cu2+–Ca2+–S100A12, the
coordinating Asp25 corresponds to His25 in S100B. There is no
ﬂexibility in this position of the coordination, which might lead to a
somewhat lower afﬁnity towards Cu2+ in S100A12 than in S100B.
Sequence alignments suggest that this Zn2+/Cu2+-binding motif is
conserved in S100A8 and S100A9 and homologous S100 proteins from
different species[20]. Noteworthy, S100B, S100A7, S100A8/A9, and
S100A12 proteins occur in the extracellular space, where they act as
cytokines [48,49]. Other Zn2+-binding proteins such as S100A2,
S100A3, or S100A6 bind Zn2+ via Cys residues and occur predomi-
nantly intracellularly. Extracellularly, Cys residues are prone to
oxidation and readily form disulﬁdes, which would abolish Zn2+
binding. The Zn2+-binding sites in S100B, S100A7, S100A8/A9, and
S100A12 built by His and Asp/Glu residues are redox-insensitive andFig. 3. Comparison of Zn2±–Ca2±–S100B with Ca2±–S100B. (A) Structural alignment of
human Zn2+–Ca2+–S100B (cyan) human Ca2+–S100B (red; pdb entry 2 H61, chains AB).
Both structures are shown as cartoons and bound Zn2+ and Ca2+ ions are shown as
spheres inmagenta and yellow, respectively. The superposition illustrates the similarity of
both structures. (B) In order to illustrate the changes induced by Zn2+ binding, the RMSD
between Zn2+–Ca2+–S100B and Ca2+–S100B is shown as color code mapped onto the
protein structure of Zn2+–Ca2+–S100B: blue, deviations between 0.1 and 0.3 Å; light blue
cyan, 0.4–0.6 Å; green, 0.7–1.0 Å; orange–red,≥1.1 Å. The largest changes in the structure
are observed at the C-terminus of helix IV. Further deviations are observed for the position
of helix III, which is also illustrated by changes in the interhelical angle between helix II
and IV (see also Table 2). (C) Superposition of human Zn2+–Ca2+–S100B (cyan) of this
study with rat Zn2+–Ca2+–S100B determined by NMR.stay functional in the extracellular space, suggesting that Zn2+
binding is important for their cytokine-like function.
2.4. Conformational changes induced by Zn2+ binding
Alignment of structures of human Ca2+–Zn2+–S100B with human
Ca2+–S100B (subunits AB, pdb code 2H61) showed that Zn2+ binding
did not induce major conformational changes (Fig. 3). Nevertheless, a
small but signiﬁcant change was observed for the conformation of the
C-terminal classical EF-hand. The interhelical angles in Zn2+–Ca2+–
S100 increased 2–3°compared to Ca2+–S100B. This ﬁnding suggests
that Zn2+ binding to Ca2+-loaded human S100B induces a more open
conformation. These changes in interhelical angle are accompanied by
rearrangements in the C-terminus involved in target protein binding.
Comparison of human Zn2+–Ca2+–S100B with the structures Ca2+–
S100B determined by NMR or X-ray crystallography shows that the
ﬂexible C-terminal region following helix IV adopts a distinct
conformation. Additional main chain hydrogen bonds are observed,
e.g., between the carbonyl oxygen of His85 and amide nitrogen of
Phe88, as well as between carbonyl oxygen of Glu86 and amide
nitrogen of Phe89 corresponding to a small elongation of helix IV.
To test whether Zn2+ binding to Ca2+–S100B induces a change in
secondary structure content in solution, CD spectra of apo-S100B,
Zn2+–S100B, Ca2+–S100B, and Zn2+–Ca2+–S100B were compared.
Addition of Ca2+ or Zn2+ leads to a small decrease in ellipticity around
222 nm. Addition of Zn2+ to Ca2+–S100B caused a further decrease
around 222 nm (Fig. 4). Such a decrease in ellipticity at 222 nm is
consistent with an increase of the α-helical content in S100B by ca. 4
residues [50]. The changes in the CD around 222 nm are also
consistent with a change in interhelical angles [51], which was
observed in the structure of Zn2+–Ca2+–S100B. In summary, the CD
spectra of S100B in solution corroborate with the structural changes
observed in the crystal. Noteworthy, sole Zn2+ binding to S100B leads
like Ca2+ binding to an exposure of hydrophobic patches to the
solvent [52] and can mediate Ca2+-independent interactions with
target proteins [31,53] or interaction with hydrophobic matrices [54].
These observations as well as the CD difference spectra suggest that
sole binding of Zn2+ induces structural changes resembling those
upon Ca2+ binding. However, it is rather unlikely that the conforma-
tional changes are due to Zn2+ binding to the EF-hands. The residuesFig. 4. Far UV CD spectra of Ca2±- and Zn2±-bound S100B. CD difference spectra of
S100B after addition of Ca2+ (1 mM), Zn2+ (1 equivalent), and Ca2+/Zn2+. Addition of
Ca2+ (line with circles) leads only to a slight decrease in ellipticity at 222 nm, which
indicates a minor increase in a-helical content. The difference spectrum shows also a
positive band at 236 nm, which might originate from contributions of phenylalanine
side chains. Zn2+ addition (line with squares) leads like Ca2+ to a decrease at 222 nm.
Addition of Ca2+ and Zn2+ (line with triangles) causes the strongest decrease at
222 nm corresponding to an increase in α-helical content of S100B homodimer by
about 4 residues.
Fig. 5. Co2± binding to S100B. The Zn2+-binding site in Ca2+-free S100B was probed
with Co2+. The spectrum of Co2+–S100B is in agreement with Co2+ coordinated by
nitrogen and oxygen atom in a distorted tetraeder.
1088 T. Ostendorp et al. / Biochimica et Biophysica Acta 1813 (2011) 1083–1091in the EF-hands provide octahedral coordination by oxygen atoms,
which are not well suited for Zn2+ binding, that prefers tetrahedral or
pentahedral coordination by nitrogen or sulfur. Recently, Moroz et al.
succeeded in structure determination of Zn2+-only-loaded S100A12
by X-ray crystallography revealing a conformation resembling an
intermediate conformation between apo and Ca2+-loaded state of
S100A12 [24].
In order to characterize the Zn2+-binding sites in S100B in the
absence of Ca2+, Co2+ was used as a spectroscopic probe. Addition of
Co2+ to apo-S100B resulted in an increase in absorption with a
maximum at 520 nm and a shoulder around 260 nm (Fig. 5). The
absorption band centered at 520 nm is due to d–d– transitions of the
Co2+, which are sensitive to the coordination geometry and nature of
ligand [55]. The location of the maximum suggests a mixed
coordination sphere of nitrogen and oxygen ligands, whereas the
shoulder around 260 nm is most likely due to nitrogen→Co2+ charge
transfer bands. The extinction coefﬁcient of the band centered at
520 nm of ca. 200 M−1 cm−1 is in agreement with coordination by
more than four ligands in distorted tetrahedral or trigonal–bipyrami-
dal coordination and ﬁts well to the observed Zn2+-binding site at pH
6.5 or pH 10 with three His and one Glu as ligands.
In the crystal structures of Zn2+–Ca2+vS100B, helix IV is slightly
straightened compared to Ca2+–S100B (Fig. 3A). This straightening is
result from amovement of His85 and Glu89/His90 to coordinate Zn2+
at the dimer interface. Thereby the residues Phe87 and Phe88 are
shifted by 2 to 6 Å (positions of Cα) towards the target-binding cleft of
S100B. This rearrangement induced by Zn2+ binding might explain
the observed increased binding afﬁnity of Zn2+–Ca2+–S100B towardsFig. 6. Comparison of conformations of the N-terminal EF-hand in different metal–ion loaded
with apo-S100B (yellow; pdb code 1B4C), (B) with human Ca2+–S100B(red; pdb code 2
spheres; Ca2+, as large spheres; Zn2+ and Cu2+, as smaller spheres. His25 of S100B and Asp
apo-S100B, His25 is already close to the position in the Zn2+–Ca2+-loaded state. Zn2+-bindin
Ca2+ binding leading to the observed increase in Ca2+ afﬁnity. (B) The structural alignment o
towards the Zn2+ ion bound to S100B. The conformation of the Ca2+ loop is not changed. (
Ca2+–S100A12 (green), indicating that the loop conformation is already optimal for Ca2+ btarget peptides like TRTK-12 [29], which interacts with Phe87 [56, 62].
Phe87 is also involved in interactions with peptides derived from p53
[58] or NDR-kinase [63]. Positioning of Phe87 and Phe88 as observed
in the structures of Zn2+–Ca2+–S100B in this study might also
increase the afﬁnity of S100B towards further target proteins.
Showing that Zn2+ already induces changes similar to those
triggered by Ca2+ binding opens the question whether Zn2+ alone
might also act as signaling ion via S100B. Previous studies showed that
Zn2+–S100B induced disassembly of microtubules and inhibited
phosphorylation of τ protein by protein kinase [10,55]. Zn2+-
dependent interaction of S100B was also shown with IQGAP1 [31],
which regulates cell morphology and motility. The results obtained
here suggest that C-terminus of Zn2+–S100B might form a target-
binding site, which is sufﬁcient for binding of some proteins.
2.5. Effect of Zn2+ binding on Ca2+ binding to EF-hands
Since Zn2+ binding to S100B leads to a 10-fold increase in Ca2+
afﬁnity [27], we examined the EF-hands for conformational changes
induced by Zn2+ binding. Interestingly, Zn2+-coordinating His25
resides in the S100-speciﬁc EF-hand loop and might play a key role in
the change of Ca2+ afﬁnity. Structural alignments of the Zn2+–Ca2+–
S100B with Ca2+–S100B showed neither notables differences in the
conformation of the N-terminal S100-speciﬁc EF-hand loop (Fig. 6B,
C) nor in the classical C-terminal EF-hand loop. The positions of the
Ca2+ ions and Ca2+–oxygen bond distances are virtually identical to
those in Ca2+–S100B. Thus, the coordination geometry for Ca2+ is
already optimal in the absence of Zn2+and the binding of Zn2+ does
not increase Ca2+ afﬁnity by changes in the conformation of the Ca2+-
binding loops. This is further supported by structural studies on
S100A12 in the Ca2+- and Cu2+–Ca2+-loaded state [20,59]. Likewise
S100B, Zn2+ binding to S100A12 increases the Ca2+ afﬁnity [60]. In
S100A12, His25 is replaced by Asp25, which is involved in Cu2+/Zn2+
coordination. Structural alignments of the EF-hands of Cu2+–Ca2+–
S100A12, Ca2+–S100A12, and Zn2+–Ca2+–S100B showed that in both
proteins, the EF-hand loops adopt the same conformation (Fig. 6C).
We therefore concluded that Zn2+ binding might lead to structural
changes that facilitate Ca2+ binding in the observed optimal
geometry.
We have shown previously that, in the structure of apo-S100A2, a
Na+ resides in the S100-speciﬁc EF-hand [61]. Similarly, a Na+ ion
was detected in the apo-structure of S100A12 [24], suggesting that at
low intracellular Ca2+ levels, the S100-speciﬁc EF-hand is occupied by
Na+. The Na+ ion is coordinated mainly by backbone carbonyls and
proposed to stabilize the apo-state, i.e., disturbing the Na+ coordina-
tion might facilitate Ca2+ binding. In S100B, one carbonyl for Na+
coordination would be provided by residue His25 involved in Zn2+
coordination. Binding of Zn2+ to S100B via the sidechain of His25states of S100B. (A) Comparison of the N-terminal EF-hand of Zn2+–Ca2+–S100B (cyan)
H61) and (C) with Cu2+–Ca2+–S100A12 (green; pdb code 1ODB). Ions are shown as
25 of S100A12 are shown in stick type. (A) The structural alignment illustrates that, in
g might induce structural changes in the Ca2+-binding loop, which facilitate subsequent
f Zn2+–Ca2+–S100B (cyan) with Ca2+–S100B (red) shows that His25 side chain moves
C) Similarly, there is no change in the conformation of the Ca2+-binding loop in Cu2+–
inding.
1089T. Ostendorp et al. / Biochimica et Biophysica Acta 1813 (2011) 1083–1091(Fig. 6B) might distort the coordination of Na+ and thereby facilitate
Ca2+ binding. Another mechanism for increasing Ca2+ afﬁnity might
be the stabilization of helix IV due to the coordination of Zn2+ by
His85′ and Glu89′/His90′. In S100 proteins, Ca2+ binding provides the
energy for solvent exposure of hydrophobic residues in the target-
binding site formed by residues of helix III, the connecting hinge loop,
and the C-terminal part of helix IV. Zn2+ binding might reduce the
required energy by helix IV stabilization, which leads in turn to a
higher Ca2+ afﬁnity.
2.6. PEG molecules in target-binding site
In the structures of Zn2+–Ca2+–S100B crystallized at pH 6.5 and
pH 10.0, a fragment of a PEG molecule present in the crystallization
buffer was resolved in the crystal structure. Both crystallization
buffers contained PEG5000MME as precipitant, whereas PEG4000
was used for crystallization at pH 9.0, where no PEG molecule was
detected. Noteworthy, the PEG molecule bound at the C-terminus of
the protein (Fig. 7). In both structures, the position of the PEG
molecule displays hydrophobic interactions with Phe42B, Phe87B,
and Phe88B. Moreover, two oxygen atoms of PEG form hydrogen
bonds to the backbone carbonyl of His42B (Fig. 7). In the structure at
pH 6.5 (Fig. 7B), there is a further polar bond between the carboxyl
oxygen of Glu45 and a PEG oxygen atom. The PEG molecule is further
stabilized in both structures by hydrophobic interactions with
His42A′ and Phe43A′ of a neighboring S100B molecule in the crystal.
Crystal packing of Zn2+–Ca2+–S100B at pH 6.5 and 10.0 in spaceFig. 7. PEGmolecule in target-binding site of S100B. A PEGmolecule was observed in the stru
in both structures adopt different conformations. However, the interactions with S100B are q
with Phe43, Phe87, and Phe88, as well as by hydrogen bonds between His42 carbonyl oxyge
carboxyl oxygen of Glu45 and a PEG oxygen atom. A Fo–Fcmap calculated after reﬁnement of
of Zn2+–Ca2+–S100B determined at pH 9.0, no PEGmolecule was observed. Crystals of Zn2+–
to space group P21. However, the packing of S100B is very similar in crystals from both spa
Zn2+–Ca2+–S100B crystals of space group C2221. On the left-hand side, a Cα-ribbon of side Zn
is shown; Ca2+ and Zn2+ ions are shown as spheres. Right-hand side depicts Zn2+–Ca2+–S
twofold crystallographic and molecular axis is perpendicular to the ﬁgure plane and indicagroup P21 is related to the packing of Zn2+–Ca2+–S100B at pH 9.0 in
space group C2221due to the molecular twofold axis of the dimer,
which is a true crystallographic axis in the structure at pH 9. Despite
that fact, Zn2+–Ca2+–S100B crystallized at pH 9.0 exhibits no binding
of PEG. Interestingly, Phe87 and Glu45 are essential for binding of
peptides derived of target proteins such as TRTK-12 [57,62] and NDR
kinase [63]. The binding of PEG to the C-terminus in the crystal
structures of Zn2+–Ca2+–S100B supports our proposal that structural
changes in the C-terminus are the cause for the increased target
protein afﬁnity of Zn2+–Ca2+–S100B versus Ca2+–S100B.
In summary, the data presented here show that the Zn2+-binding
sites in S100B are ﬂexible metal ion-binding sites most likely adapted
to accommodate Zn2+ and Cu2+with high afﬁnity. Zn2+ binding leads
to a stabilization of the C-terminal part of helix IV, which increases the
binding afﬁnity towards target peptides and might also contribute to
the increase in Ca2+ afﬁnity. Further structural studies on the
structure of Zn2+–S100B are in progress, which will help to
understand how the Ca2+ afﬁnity in S100 protein is regulated.Acknowledgments
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